Feature Channels: Infectious Diseases

• share
• favorite_border

• share
• favorite_border

Over the past decade, decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. and globally. Researchers discuss the multifactorial barriers including increasing vaccine hesitancy and new clinical and public health challenges in vaccinations of U.S. adults.

• share
• favorite_border

Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government’s Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and destructive strains of herpesviruses that latently infect a majority of Americans and can lead to acute infections, multiple forms of cancer, autoimmune disease and birth defects.

• share
• favorite_border

The question isn’t if, but when, the next pandemic will hit. Research and observation have identified strong potential for the next pandemic-causing virus to come from one or more of five different virus families.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

A new study led by researchers at Johns Hopkins Bloomberg School of Public Health estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent plasma had been used more broadly, particularly in outpatients at high risk for severe disease and in hospitalized patients during their first few days of admission.

• share
• favorite_border

With free COVID-19 rapid tests now shipping to households nationwide, and many other types of at-home medical tests now available, a new study looks at what older adults think about the ability to get answers to medical questions without leaving home.

• share
• favorite_border

The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments for an infection that leads to hospitalization or worse for hundreds of thousands of people in the United States each year, according to the Centers for Disease Control and Prevention. New images of the virus from researchers at the University of Wisconsin–Madison may hold the key to preventing or slowing RSV infections.

• share
• favorite_border

September usually marks the start of flu season, and with the ongoing threat of COVID-19, it’s crucial to be vigilant about your family’s health. The challenge, however, is being able to tell the difference between the flu, the common cold, respiratory syncytial virus (RSV) and COVID-19, since all have similar symptoms.

• share
• favorite_border

New findings on how past viral respiratory infections affect future, unrelated ones could lead to therapies for boosting general antiviral immunity—and potentially better pandemic preparedness.

• share
• favorite_border

A study of more than 28,000 pregnancies from 2022 has found that the majority of pregnant people received the COVID-19 vaccine during its initial release.

• share
• favorite_border

In a new study funded by the National Institutes of Health, University of Georgia researchers found that natural immunity from previous flu infections has a significant impact on how well future influenza vaccinations work.

• share
• favorite_border

Experts from Cedars-Sinai Guerin Children’s are available to discuss a range of pediatric topics, including infectious diseases, adolescent weight management and the latest pediatric research coming out of the American Academy of Pediatrics (AAP) annual conference happening Sept. 27-Oct. 1 in Orlando, Florida.

• share
• favorite_border

If it’s autumn, then it must be influenza season, which means it’s time to consider flu shots for your family.The U.S. Centers for Disease Control and Prevention (CDC), American Academy of Pediatrics, and Infectious Diseases Society of America recommend that everyone approved to receive a flu shot get one—including children ages 6 months and older.

• share
• favorite_border